Wavelength Pharmaceuticals (Israel)
Wavelength Pharmaceuticals is an independent API company of choice for pharmaceutical industry leaders that require advanced API solutions to gain sustainable, competitive advantages.
Founded in Israel in 1987 and active in Japan since 2002, with more than 250 customers in 50 countries, Wavelength’s cGMP-compliant facility is a first-class operation recognized for excellence in safety, and environmental stewardship having more than 30 years of exceptional regulatory track record with leading global regulatory authorities such as USFDA, EU-EMA, PMDA, TGA, KFDA, ANVISA and COFEPRIS.
Wavelength has strong expertise in complex chemistry, innovative process development, crystalline forms and particle design and offers a wide range of APIs across many different therapeutic categories including Steroids, Hormones and Cytotoxics.
